Thermo Fisher’s $10B Bet on Clinical Trial Digitalization
Thermo Fisher Scientific is closing in on one of the largest healthcare technology acquisitions of 2024 with a potential $10 billion takeover of clinical trial software provider Clario. The deal represents a strategic pivot toward digital infrastructure in pharmaceutical research.